PHMR

Canadian province tries decriminalizing medication to struggle overdose disaster

by

VANCOUVER, Jan 31 (Reuters) – The western Canadian province of British Columbia on Tuesday started a three-year pilot program to cease prosecuting folks for carrying small quantities of heroin, meth, ecstasy, or crack cocaine, as a part of an effort to struggle a drug overdose disaster. B.C. accounts for a few third of the 32,000 … Read more

U.S. CDC nonetheless potential stroke danger from Pfizer bivalent COVID shot

by

Jan 26 (Reuters) – New information from one U.S. Facilities for Illness Management and Prevention (CDC) database reveals a doable stroke danger hyperlink for older adults who acquired an up to date Pfizer (PFE.N)/BioNTech (22UAy.DE) COVID-19 booster shot, however the sign is weaker than what the company had flagged earlier in January, well being officers … Read more

Unique: WHO investigating hyperlinks between cough syrup deaths, considers recommendation for folks

by

Jan 24 (Reuters) – The World Well being Group (WHO) is investigating whether or not there’s any connection between producers whose contaminated cough syrups it has linked to the deaths of greater than 300 kids in three international locations, an individual acquainted with the matter instructed Reuters. Citing “unacceptable ranges” of poisons within the merchandise, … Read more

China says vital COVID instances have peaked as vacation journey surges

by

Thousands and thousands journey throughout nation for Lunar New Yr President Xi says nervous about aged, rural areas Each day deaths might hit 36,000 subsequent week, evaluation exhibits Chinese language drugmakers rush to make fever medicines BEIJING, Jan 19 (Reuters) – The variety of COVID sufferers needing vital care in China’s hospitals has peaked, well … Read more

China COVID peak to final two-three months, hit rural areas subsequent

by

Peak of COVID wave seen lasting 2-3 months – epidemiologist Aged in rural areas notably in danger Folks mobility indicators tick up, however but to totally get better BEIJING, Jan 13 (Reuters) – The height of China’s COVID-19 wave is predicted to final two to 3 months, and can quickly swell over the huge countryside … Read more

China imposes transit curbs for S.Korea, Japan in rising COVID spat

by

New curbs for S.Korea, Japan nationals transiting China China says visa suspensions for S.Korea, Japan “cheap” Escalating diplomatic spat could complicate financial relations Social media customers lash out at S.Korea’s “insulting” COVID curbs BEIJING, Jan 11 (Reuters) – China launched transit curbs for South Korean and Japanese nationals on Wednesday, in an escalating diplomatic spat … Read more

Pfizer CEO guidelines out generic COVID drug Paxlovid for China

by

Jan 9 (Reuters) – Pfizer Inc (PFE.N) isn’t in talks with Chinese language authorities to license a generic model of its COVID-19 remedy Paxlovid to be used there, however is in discussions a couple of worth for the branded product, Chief Govt Albert Bourla mentioned on Monday. Reuters reported on Friday that China was in … Read more

China retaliates in opposition to South Korea, Japan over COVID curbs

by

China embassy decries “discriminatory” S.Korea border guidelines Some cities say peak of COVID infections was final month Chinese language state media criticise Pfizer over Paxlovid value BEIJING, Jan 10 (Reuters) – China started retaliating on Tuesday in opposition to South Korea and Japan, two of the international locations which have imposed COVID-19 curbs on travellers … Read more

China’s ‘nice migration’ kicks-off beneath shadow of COVID

by

SHANGHAI, Jan 7 (Reuters) – China on Saturday marked the primary day of “chun yun”, the 40-day interval of Lunar New Yr journey recognized pre-pandemic because the world’s largest annual migration of individuals, bracing for an enormous improve in travellers and the unfold of COVID-19 infections. This Lunar New Yr public vacation, which formally runs … Read more

Eisai, Biogen receives U.S. FDA approval for Alzheimer’s drug, applies for full approval

by

Jan 7 (Reuters) – The U.S. Meals and Drug Administration on Friday accepted the Alzheimer’s drug lecanemab developed by Eisai Co Ltd (4523.T) and Biogen Inc (BIIB.O) for sufferers within the earliest levels of the mind-wasting illness. Eisai and Biogen stated on Saturday the Japanese drugmaker had utilized for full FDA approval of the drug. … Read more